Status:
UNKNOWN
Egg White for Phosphorus Control in Haemodialysis Patients
Lead Sponsor:
Federico II University
Conditions:
Renal Insufficiency, Chronic
Dialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To evaluate the effect on phosphatemia in hemodialysis patients of replacing the meat or fish included in two meals a week with an amount of egg white containing the same quantity of proteins.
Detailed Description
Hyperphosphatemia develops in the majority of patients with end-stage renal disease (ESRD). It is responsible for severe complications such as mineral bone disease, and has a role in worsening the car...
Eligibility Criteria
Inclusion
- thrice weekly 4 h standard bicarbonate HD treatment with an at least 6-month vintage
- stable dialysis dose and modality at least by 3 months
- hyperphosphataemia (serum phosphate ≥5.0 mg/dl) at least by 3 months
- stable dietary intake at least by 3 months
- stable body weight at least by 3 months
- stable biochemical markers at least by 3 months
Exclusion
- diabetes
- liver disease
- malignancy
- previous parathyroidectomy
- psychiatric diseases
- non-collaborative patients
Key Trial Info
Start Date :
June 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2017
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03236701
Start Date
June 15 2017
End Date
December 15 2017
Last Update
September 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federico II University Hospital
Napoli, Italy, 80131